13F HOLDINGS REPORT
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Quarter ended Q3 2023 · Filed August 8, 2023 · Accession 0000950123-23-006845
Total Value
$328.5M
Positions
61
Other Managers
0
Confidential Omitted
No
Holdings (61)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AMGEN INC COM | AMGN | 117,246 | $26.0M | 7.92% |
| 2 | INCYTE CORP | INCY | 358,454 | $22.3M | 6.79% |
| 3 | HARMONY BIOSCIENCES HLDGS | HRMY | 570,500 | $20.1M | 6.11% |
| 4 | REGENERON PHARMS. | REGN | 27,000 | $19.4M | 5.91% |
| 5 | SUPERNUS PHARMS. | SUPN | 523,500 | $15.7M | 4.79% |
| 6 | VERA THERAPEUTICS | VERA | 975,227 | $15.6M | 4.76% |
| 7 | ALNYLAM PHARMS. | ALNY | 81,600 | $15.5M | 4.72% |
| 8 | APELLIS PHARMS. | APLS | 129,700 | $11.8M | 3.60% |
| 9 | UNITED THERAPEUTICS CORP DEL | UTHR | 52,759 | $11.6M | 3.55% |
| 10 | INTRA-CELLULAR THERAPIES | 46116X101 | 176,856 | $11.2M | 3.40% |
| 11 | GILEAD SCIENCES | GILD | 144,584 | $11.1M | 3.39% |
| 12 | ILLUMINA INC | ILMN | 50,500 | $9.5M | 2.88% |
| 13 | MIRATI THERAPEUTICS INC | 60468T105 | 260,000 | $9.4M | 2.86% |
| 14 | VERTEX PHARMACEUTICALS INC | VRTX | 21,000 | $7.4M | 2.25% |
| 15 | REVANCE THERAPEUTICS INC | 761330109 | 288,726 | $7.3M | 2.22% |
| 16 | HORIZON THERAPEUTICS | G4617B105 | 67,000 | $6.9M | 2.10% |
| 17 | TRAVERE THERAPEUTICS INC | TVTX | 441,019 | $6.8M | 2.06% |
| 18 | NEUROCRINE BIOSCIENCES | NBIX | 68,877 | $6.5M | 1.98% |
| 19 | KARUNA THERAPEUTICS INC | 48576A100 | 25,700 | $5.6M | 1.69% |
| 20 | AURINIA PHARMACEUTICALS INC | AUPH | 573,530 | $5.6M | 1.69% |
| 21 | DENALI THERAPEUTICS | DNLI | 188,000 | $5.5M | 1.69% |
| 22 | KRYSTAL BIOTECH | KRYS | 45,945 | $5.4M | 1.64% |
| 23 | BIOMARIN PHARM. | BMRN | 58,656 | $5.1M | 1.55% |
| 24 | MADRIGAL PHARMS. | MDGL | 18,300 | $4.2M | 1.29% |
| 25 | AXSOME THERAPEUTICS | AXSM | 58,300 | $4.2M | 1.27% |
| 26 | ERASCA INC | ERAS | 1,426,000 | $3.9M | 1.19% |
| 27 | ULTRAGENYX PHARM. | RARE | 80,052 | $3.7M | 1.12% |
| 28 | AKERO THERAPEUTICS INC | 00973Y108 | 78,489 | $3.7M | 1.11% |
| 29 | ACADIA PHARMACEUTICALS IN | ACAD | 151,000 | $3.6M | 1.10% |
| 30 | HALOZYME THERAPEUTICS INC | HALO | 95,500 | $3.4M | 1.05% |
| 31 | DYNE THERAPEUTICS | DYN | 300,751 | $3.4M | 1.03% |
| 32 | BIOGEN INC | BIIB | 11,000 | $3.1M | 0.95% |
| 33 | ROCKET PHARMS. | RCKTW | 156,000 | $3.1M | 0.94% |
| 34 | LEGEND BIOTECH | LEGN | 38,000 | $2.6M | 0.80% |
| 35 | Zai Lab Ltd ADR (V1 Ord) | ZLAB | 78,958 | $2.2M | 0.67% |
| 36 | SAREPTA THERAPEUTICS INC | SRPT | 18,800 | $2.2M | 0.66% |
| 37 | JAZZ PHARMS. | JAZZ | 17,200 | $2.1M | 0.65% |
| 38 | IONIS PHARMS. | IONS | 43,000 | $1.8M | 0.54% |
| 39 | MIRUM PHARMACEUTICALS INC | MIRM | 67,500 | $1.7M | 0.53% |
| 40 | CELLDEX THERAPEUTICS INC NEW | CLDX | 48,099 | $1.6M | 0.50% |
| 41 | BEIGENE ADR | BEIGF | 8,700 | $1.5M | 0.47% |
| 42 | NOVOCURE LTD | NVCR | 32,000 | $1.3M | 0.40% |
| 43 | GUARDANT HEALTH | GH | 36,500 | $1.3M | 0.40% |
| 44 | CYTOKINETICS INC | CYTK | 37,000 | $1.2M | 0.37% |
| 45 | XENON PHARMACEUTICALS INC | XENE | 25,500 | $981,750 | 0.30% |
| 46 | INTELLIA THERAPEUTICS | NTLA | 24,000 | $977,760 | 0.30% |
| 47 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 90,000 | $977,400 | 0.30% |
| 48 | SAGE THERAPEUTICS INC | 78667J108 | 20,000 | $939,400 | 0.29% |
| 49 | I-MAB-SPONSORED ADR | NBP | 310,499 | $925,287 | 0.28% |
| 50 | INSMED INC | INSM | 40,100 | $845,308 | 0.26% |
| 51 | HUTCHMED CHINA LTD | HMDCF | 68,000 | $816,000 | 0.25% |
| 52 | BEAM THERAPEUTICS INC | BEAM | 23,500 | $750,355 | 0.23% |
| 53 | PTC THERAPEUTICS | PTCT | 17,000 | $691,730 | 0.21% |
| 54 | AGIOS PHARMS. | AGIO | 24,000 | $679,680 | 0.21% |
| 55 | PROTAGONIST THERAPEUTICS INC | PTGX | 19,900 | $549,240 | 0.17% |
| 56 | AMYLYX PHARMACEUTICALS INC | AMLX | 25,000 | $538,500 | 0.16% |
| 57 | VENTYX BIOSCIENCES INC | 92332V107 | 15,000 | $491,400 | 0.15% |
| 58 | IOVANCE BIOTHERAPEUTICS | IOVA | 65,000 | $456,950 | 0.14% |
| 59 | ARVINAS INC | ARVN | 17,000 | $421,090 | 0.13% |
| 60 | UNIQURE NV | QURE | 15,500 | $177,630 | 0.05% |
| 61 | RELMADA THERAPEUTICS | RLMD | 10,000 | $24,700 | 0.01% |